Ebola Bundibugyo Virus Disease Outbreak – Democratic Republic of Congo
The Democratic Republic of the Congo (DRC) is currently experiencing an outbreak of Bundibugyo virus disease (BVD) in Ituri province. BVD is one of the known species of Ebola virus and belongs to the genus Ebolavirus. This outbreak has prompted a Level 2 travel alert from the CDC, recommending travelers to exercise increased caution.
About Bundibugyo Virus Disease
Bundibugyo virus was first identified in 2007 and is transmitted to humans through contact with blood or body fluids of infected animals (likely fruit bats, which are considered the natural reservoir) or infected persons. The virus causes severe illness with a fatality rate that varies but is generally lower than some other Ebola species, historically ranging from approximately 25-50% in previous outbreaks.
Transmission and Risk Factors
Human-to-human transmission occurs through direct contact with blood or body fluids of infected individuals, or contact with surfaces and materials contaminated by these fluids. Healthcare workers and family members caring for patients face elevated risk. The virus does not spread through air, water, or food.
Travel Recommendations
- Avoid travel to affected areas in Ituri province unless essential
- If travel is necessary, maintain strict infection prevention practices
- Ensure access to reliable healthcare facilities prior to travel
- Practice rigorous hand hygiene and use appropriate personal protective equipment when indicated
- Avoid contact with blood, body fluids, or tissues of any person, living or deceased
- Avoid contact with animals, particularly fruit bats and primates
Healthcare Preparedness
Travelers should locate reliable medical facilities in advance and maintain travel health insurance with evacuation coverage. Notify healthcare providers of potential Ebola exposure if illness develops within 21 days of leaving affected areas.
Pharmacist's note: No specific antiviral medications are FDA-approved for Bundibugyo virus disease treatment. Management is supportive, focusing on maintaining fluid/electrolyte balance and managing symptoms. Travelers should not self-medicate; any fever or illness within 21 days of exposure warrants immediate medical evaluation. Vaccination against Zaire Ebola is available but does not protect against Bundibugyo virus. Carry prescription medications in original containers and maintain comprehensive travel health insurance.